By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Tesaro, Inc. (Waltham, Massachusetts) 

309 Waverley Oaks Road
Suite #101
Waltham  Massachusetts  02452  U.S.A.
Phone: 339-970-0900 Fax: n/a



Company News
Myriad Genetics (MYGN)’s myChoice HRD Test Successfully Identifies Patients That Meet Primary Endpoint In Tesaro (TSRO)’s Pivotal Phase 3 Ovarian Cancer Study With Niraparib 6/29/2016 6:58:24 AM
Tesaro (TSRO)'s Phase III NOVA Trial of Niraparib Hits Primary Endpoint; NDA and MAA Planned for Q4 2016 6/29/2016 6:27:06 AM
Tesaro (TSRO) Announces Rolapitant Data Presentations At The 2016 MASCC/ISOO Annual Meeting On Supportive Care In Cancer 6/24/2016 9:16:00 AM
Wuxi Biologics Congratulates Tesaro (TSRO) For Anti-TIM-3 Antibody IND Submission In The U.S. 5/10/2016 11:24:43 AM
Tesaro (TSRO) Announces First-Quarter 2016 Operating Results 5/6/2016 8:06:33 AM
Tesaro (TSRO) Announces Submission Of Investigational New Drug Application For Anti-TIM-3 Antibody TSR-022 To The FDA 4/25/2016 9:29:27 AM
Tesaro (TSRO) To Announce First Quarter 2016 Financial Results On May 5, 2016 4/22/2016 8:39:27 AM
Massachusetts' Tesaro (TSRO) Inks $450 Million Prostate Cancer Deal with Drug Giant Johnson & Johnson (JNJ) 4/6/2016 6:38:47 AM
Tesaro (TSRO) Announces Appointment Of Dr. Kavita Patel To Board Of Directors 4/4/2016 9:51:40 AM
Tesaro (TSRO) Announces Enrollment Of First Patient In Phase 1 Clinical Trial Of TSR-042 3/29/2016 9:50:19 AM